Activity of daptomycin with or without 25 percent ethanol compared to combinations of minocycline, EDTA, and 25 percent ethanol against methicillin-resistant Staphylococcus aureus isolates embedded in biofilm

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 4, 2013, Pages 1998-2000

  Estes, R ^a   Theusch, J ^a   Beck, A ^b   Pitrak, D ^a   Mullane, Kathleen M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; DAPTOMYCIN; EDETIC ACID; MINOCYCLINE; SILICON;

ANTIBIOTIC LOCK THERAPY; ANTIBIOTIC THERAPY; ARTICLE; AUTOCLAVE; BACTERIAL CLEARANCE; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; BIOFILM; BLOODSTREAM INFECTION; CATHETER INFECTION; CENTRAL VENOUS CATHETER; COLONY FORMING UNIT; DISEASE SEVERITY; DRUG ACTIVITY; ENDOCARDITIS; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; SEPSIS; SUPPURATIVE THROMBOPHLEBITIS; THROMBOPHLEBITIS;

BIOFILMS; DAPTOMYCIN; DRUG COMBINATIONS; EDETIC ACID; ETHANOL; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MINOCYCLINE;

EID: 84875205433     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01129-12     Document Type: Article

References (21)

1. O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II, Randolph AG, Rupp ME, Saint S, Healthcare Infection Control Practices Advisory Committee. 2011. Guidelines for the prevention of intravascular catheterrelated infections. Clin. Infect. Dis. 52:e162-e193.
2. Maki DG, Weise CE, Sarafin HW. 1977. A semiquantitative culture method for identifying intravenous-catheter-related infection. N. Engl. J. Med. 296:1305-1309.
3. Mermel LA, McCormick RD, Springman SR, Maki DG. 1991. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am. J. Med. 91:197S-205S.
4. Safdar N, Maki DG. 2004. The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Intensive Care Med. 30:62-67.
5. Dobbins BM, Kite P, Kindon A, McMahon MJ, Wilcox MH. 2002. DNA fingerprinting analysis of coagulase negative staphylococci implicated in catheter related bloodstream infections. J. Clin. Pathol. 55:824-828.
6. Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP. 1993. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J. Infect. Dis. 168:400-407.
7. Anaissie E, Samonis G, Kontoyiannis D, Costerton J, Sabharwal U, Bodey G, Raad I. 1995. Role of catheter colonization and infrequent hematogenous seeding in catheter-related infections. Eur. J. Clin. Microbiol. Infect. Dis. 14:134 -137.
8. Raad I, Hanna HA, Awad A, Alrahwan A, Bivins C, Khan A, Richardson D, Umphrey JL, Whimbey E, Mansour G. 2001. Optimal frequency of changing intravenous administration sets: is it safe to prolong use beyond 72 hours? Infect. Control Hosp. Epidemiol. 22:136 -139.
9. National Nosocomial Infections Surveillance System. 1999. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999. Am. J. Infect. Control 27:520 -532.
10. National Nosocomial Infections Surveillance System. 2001. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992-June 2001, issued August 2001. Am. J. Infect. Control 6:404-421.
11. Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP, the SCOPE Participant Group. 1998. National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn. Microbiol. Infect. Dis. 30:121-129.
12. Pittet D, Tarara D, Wenzel RP. 1994. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 271:1598 -1601.
13. Sanders J, Pithie A, Ganly P, Surgenor L, Wilson R, Merriman E, Loudon G, Judkins R, Chambers S. 2008. A prospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in immunosuppressed haematology patients. J. Antimicrob. Chemother. 62:809-815.
14. Mermel L, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, Raad II, Rijnders BJA, Sherertz RJ, Warren DK. 2009. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 49:1-45.
15. Hanberger H, Nilsson LE, Maller R, Isaksson B. 1991. Pharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis and Staphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of Ca2+ and albumin on these drugs. Antimicrob. Agents Chemother. 35:1710 -1716.
16. Louie A, Baltch AL, Ritz WJ, Smith RP, Asperilla M. 1993. Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci. Chemotherapy 39:302-309.
17. Rybak MJ, Hershberger E, Moldovan T, Grucz RG. 2000. In vitro activities of daptomycin, vancomycin, linezolid, and quinupristindalfopristin against staphylococci and enterococci, including vancomycin-intermediate and -resistant strains. Antimicrob. Agents Chemother. 44:1062-1066.
18. Snydman DR, Jacobus NV, McDermott LA, Lonks JR, Boyce JM. 2000. Comparative in vitro activities of daptomycin and vancomycin against resistant gram-positive pathogens. Antimicrob. Agents Chemother. 44: 3447-3450.
19. Tally FP, Zeckel M, Wasilewski MM, Carini C, Berman CL, Drusano GL, Oleson FB, Jr. 1999. Daptomycin: a novel agent for Gram-positive infections. Expert Opin. Invest. Drugs 8:1223-1238.
20. Mascio CTM, Alder JD, Silverman JA. 2007. Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells. Antimicrob. Agents Chemother. 51:4255-4260.
21. Raad I, Hanna H, Jiang Y, Dvorak T, Teitzel R, Chaiban G, Sherertz R, Hachem R. 2007. Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob. Agents Chemother. 51:1656 -1660.